Option Care Health, Inc. (NASDAQ:OPCH) Receives $29.92 Consensus PT from Analysts

Option Care Health, Inc. (NASDAQ:OPCH – Get Free Report) has been assigned an average rating of “Moderate Buy” from the fourteen brokerages that are presently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $29.9231.

A number of equities research analysts have issued reports on OPCH shares. Weiss Ratings raised Option Care Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Tuesday, August 11th. The Goldman Sachs Group initiated coverage on Option Care Health in a report on Monday, June 8th. They set a “neutral” rating and a $22.00 price objective on the stock. Zacks Research upgraded shares of Option Care Health from a “strong sell” rating to a “hold” rating in a research report on Monday, July 6th. Wall Street Zen upgraded shares of Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. Finally, TD Cowen lowered their price objective on shares of Option Care Health from $37.00 to $23.00 and set a “hold” rating on the stock in a research report on Friday, May 1st.

Get Option Care Health alerts:

View Our Latest Report on OPCH

Hedge Funds Weigh In On Option Care Health

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Durable Capital Partners LP increased its position in Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after acquiring an additional 4,720,988 shares during the period. Fuller & Thaler Asset Management Inc. increased its holdings in shares of Option Care Health by 12.1% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock valued at $221,707,000 after purchasing an additional 752,058 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in shares of Option Care Health by 6.2% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock valued at $135,355,000 after purchasing an additional 247,118 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Option Care Health by 0.9% during the first quarter. Dimensional Fund Advisors LP now owns 3,876,856 shares of the company’s stock worth $104,368,000 after purchasing an additional 36,208 shares during the last quarter. Finally, Southpoint Capital Advisors LP raised its stake in shares of Option Care Health by 20.0% during the first quarter. Southpoint Capital Advisors LP now owns 3,600,000 shares of the company’s stock worth $96,912,000 after purchasing an additional 600,000 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Stock Up 0.9%

NASDAQ:OPCH opened at $23.70 on Friday. The company has a quick ratio of 0.98, a current ratio of 1.47 and a debt-to-equity ratio of 0.91. The stock’s fifty day moving average is $22.36 and its two-hundred day moving average is $25.58. Option Care Health has a 52 week low of $18.01 and a 52 week high of $36.80. The stock has a market capitalization of $3.55 billion, a price-to-earnings ratio of 17.82, a price-to-earnings-growth ratio of 1.37 and a beta of 0.65.

Option Care Health (NASDAQ:OPCH – Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The firm had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.42 billion. During the same quarter in the previous year, the business posted $0.41 earnings per share. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. Research analysts anticipate that Option Care Health will post 1.69 EPS for the current year.

About Option Care Health

(Get Free Report)

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.

Featured Stories

• Five stocks we like better than Option Care Health
• 2 Biotech Stocks Shaping Up for Major Breakouts
• 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
• 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
• Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.